The country comparison is defined more by payment design and clinical governance than by the overall CAGR range
Bloating and Constipation on GLP-1s Bloating and constipation are the two most common digestive complaints on GLP-1s, and they usually trace back to the same root cause: slower transit
Do not take another dose on your originally scheduled day
"The lowest dose is almost never the dose that people wind up being on," said Korner
Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity
Specifically, be concerned if weight loss stalls completely for more than 3 weeks despite caloric deficit, if appetite suppression is noticeably weaker than during initial weeks, if you do not notice any thermogenic effect, or if your weekly weight loss rate drops below half of what clinical trials show for your dose level